Xtalks

📬 Stay up-to-date with the latest developments in life sciences in the February 2025 edition of the Xtalks Community Connection newsletter! 🌟 This month, we're bringing you cutting-edge webinars on clinical trials, pharmaceutical regulation and medical devices. Don’t miss our Spotlight with M4 Knick on the impact of digital tools in pharmaceutical liquid analytics, and our podcast with Digital Medicine Society (DiMe) and the Critical Path Institute (C-Path). We’re also featuring the leading green pharma and biotech companies driving sustainability in 2025. Plus, check out our current job openings in the industry, and share your thoughts on the fastest-growing sector in the next five years in our monthly poll. All this and more below ⬇️ #LifeSciences #Pharma #DrugDiscovery #ClinicalTrials #MedicalDevices #Sustainability #GreenPharma #TechRevolution #Innovation #Hiring #Poll

❓ How can hydrophilic vascular coatings improve medical device performance? Join dsm-firmenich’s webinar with Jayme Paullin to explore the latest advancements in hydrophilic coatings designed to reduce thrombosis and minimize trauma. Learn about the properties, performance, and application of these coatings, including their impact on lubricity, durability, biocompatibility, and hemocompatibility. This session will provide valuable insights for product developers, engineers, and innovators in the medical device industry. Register now: https://buff.ly/3CWo43i #MedicalDevices #HydrophilicCoatings #PatientCare #Innovation #Webinar #dsmfirmenich

Our latest blog unveils insights on the largest publicly traded healthcare companies by market cap in 2025. Explore how companies such as Elevance Health, Molina Healthcare, and Doximity Hospital Solutions are setting new industry standards at https://buff.ly/4ihcXkL by Soumya Shashikumar.

❓ How can early glycan screening revolutionize cell line development (CLD) and accelerate biologic quality? Join Advanced Instruments, LLC's webinar with Sebastian Giehring and Andrea Gough to explore how high-throughput glycan screening integrates into the Solentim ecosystem for CLD automation. Learn how this process improves accuracy, efficiency, and clone progression for biosimilars and glycan-engineered antibodies. Discover practical strategies for biologic excellence with early glycan insights, and hear from case studies on optimizing workflows. Register now: Broadcast 1 – UK & Europe 8am EST / 1pm GMT / 2pm CET https://buff.ly/4gClDR6 Broadcast 2 – North America 2pm PST / 4pm CST / 5pm EST https://buff.ly/4aSj9gv #CellLineDevelopment #Biologics #GlycanScreening #CLD #Webinar #AdvancedInstruments

The FDA has approved SpringWorks Therapeutics’ Gomekli (mirdametinib) for the treatment of the rare genetic disorder neurofibromatosis type 1 (NF1) in both adult and pediatric patients. Read more at https://buff.ly/4jZ7hgz by Ayesha Rashid about Gomekli, which has become the first approved treatment for the condition in both adults and children.

Our January 2025 MedTech M&A Roundup is live — spotlighting acquisitions from Stryker to Boston Scientific that are reshaping device innovation. Learn more by Soumya Shashikumar at https://buff.ly/4gHkQib.

KalVista Pharmaceuticals, Inc. presented new data on sebetralstat at the recent WSAAI 2025 Meeting in Hawaii. The findings shed light on patient adherence to long-term prophylaxis (LTP) treatments for hereditary angioedema (HAE) and sebetralstat’s efficacy as an oral on-demand therapy. Read more at https://buff.ly/4hED5pM by Ayesha Rashid.

Our January 2025 Healthcare M&A Roundup is live! Discover key acquisitions reshaping provider networks and digital health for improved patient outcomes by Soumya Shashikumar at https://buff.ly/3X1JQtf.

❓ How can we overcome the challenges of cross-border patient participation in rare disease clinical trials? Join Medpace’s webinar with Michelle Petersen, James Thomas, Beate Hess, and Carly Wolnitzek to explore strategies for successful cross-border patient enrollment and retention. Learn from their extensive experience in managing global trials for rare diseases, addressing key considerations such as site selection, patient transportation, language barriers, and regulatory differences. Gain insights into operational strategies and methods for enhancing the patient experience to ensure successful rare disease trials. Register now: https://buff.ly/4hPn2F6 #RareDisease #ClinicalTrials #PatientRecruitment #CrossBorderTrials #Webinar #Medpace